Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching C Lau

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
BMC Cancer|August 10, 2004
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcomaTsz-Kwong Man, Xin-Yan Lu, Kim Jaeweon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
Expert Review of Neurotherapeutics|April 12, 2007
What is the best adjuvant treatment for very young patients with medulloblastoma?James W Clarke, Mersiha Hadziahmetovic, Katherine Tzou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cellsXiao-Nan Li, Suhag Parikh, Qin Shu, et al.
Cancer Research|March 12, 2009
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progressionOu Ma, Wei-Wen Cai, Lars Zender, et al.
Pharmaceutical Research|November 9, 2013
The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cellsShiguo Zhu, Cecele J Denman, Zehra S Cobanoglu, et al.
International Journal of Molecular Sciences|July 27, 2022
Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric OsteosarcomaAaron M Taylor, Jiayi M Sun, Alexander Yu, et al.
Neuro-Oncology Advances|June 30, 2025
Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting reportScott L Coven, Roberta McKean-Cowdin, Michael E Scheurer, et al.
Journal of Neuro-Oncology|August 14, 2014
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomasWan-Yee Teo, M Tarek Elghetany, Jianhe Shen, et al.
Cancer|August 17, 2016
A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LGRicardo J Flores, Aaron J Kelly, Yiting Li, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
BMC Cancer|August 10, 2004
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcomaTsz-Kwong Man, Xin-Yan Lu, Kim Jaeweon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
Expert Review of Neurotherapeutics|April 12, 2007
What is the best adjuvant treatment for very young patients with medulloblastoma?James W Clarke, Mersiha Hadziahmetovic, Katherine Tzou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cellsXiao-Nan Li, Suhag Parikh, Qin Shu, et al.
Cancer Research|March 12, 2009
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progressionOu Ma, Wei-Wen Cai, Lars Zender, et al.
Pharmaceutical Research|November 9, 2013
The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cellsShiguo Zhu, Cecele J Denman, Zehra S Cobanoglu, et al.
International Journal of Molecular Sciences|July 27, 2022
Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric OsteosarcomaAaron M Taylor, Jiayi M Sun, Alexander Yu, et al.
Neuro-Oncology Advances|June 30, 2025
Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting reportScott L Coven, Roberta McKean-Cowdin, Michael E Scheurer, et al.
Journal of Neuro-Oncology|August 14, 2014
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomasWan-Yee Teo, M Tarek Elghetany, Jianhe Shen, et al.
Cancer|August 17, 2016
A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LGRicardo J Flores, Aaron J Kelly, Yiting Li, et al.
Pageof 12